PROPUBLICA Fearless Reporting for an Informed Society — Join Us.
DONATE
Skip to content
ProPublica Donate
ProPublica Donate

Ludwig Institute For Cancer Research

Organization summary

Type of Nonprofit

Designated as a Organizations for any of the following purposes: religious, educational, charitable, scientific, literary, testing for public safety, fostering national or international amateur sports competition (as long as it doesn't provide athletic facilities or equipment), or the prevention of cruelty to children or animals.

Donations to this organization are tax deductible.

Summary charts: organization finances over time

Revenue
$72.9M (2023)

Expenses
$71.4M (2023)

Total Assets
$19.3M (2023)

Total Liabilities
$16.6M (2023)

Source: Form 990 tax filings from 2011 to 2023

Tax Filings and Audits by Year

Form 990 is an information return that most organizations claiming federal tax-exempt status must file yearly with the IRS. Nonprofit Explorer has IRS digitized Form 990 data for filings processed in 2012 and later. If this organization filed an amended return, it may not be reflected below. Duplicate download links may indicate a resubmission or amendment to this organization's original return. Form 990 data is from the IRS.

Audits are required to be submitted by nonprofit organizations that spend $750,000 or more in federal grant money in a fiscal year. "Single audits" look at the entire organization's finances and compliance, while other audits are program specific. Nonprofit Explorer has PDFs of audits for some nonprofits for fiscal year 2015 and later. Audit data is from the Federal Audit Clearinghouse.

Fiscal Year Ending Dec.
2023

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$72,893,952
Expenses
$71,353,269
Net Income
$1,540,683
Net Assets
$2,683,472
Notable Sources of Revenue Percent of Total Revenue
Contributions $70,226,776
96.3%
Program Services $0
Investment Income $12,667
0.0%
Bond Proceeds $0
Royalties $2,602,164
3.6%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $52,345
0.1%
Notable Expenses Percent of Total Expenses
Executive Compensation $4,029,990
5.6%
Professional Fundraising Fees $0
Other Salaries and Wages $8,986,528
12.6%
Assets/Debt
Total Assets $19,252,124
Total Liabilities $16,568,652
Net Assets $2,683,472
Compensation
Key Employees and Officers Compensation Related Other
Dr Chi Van Dang (Director, Scientific Director) $1,051,303 $0 $75,277
Dr Jonathan Skipper (Exec Vice Pres Tech Develop.) $791,046 $0 $75,277
Thomas Baenninger (Chief Financial Officer) $512,250 $0 $112,712
Richard White (Group Leader) $472,041 $0 $105,307
Yang Shi (Group Leader) $438,227 $0 $59,255
Dr Richard Kolodner (Group Leader) $416,477 $0 $51,279
George Coukos (Branch Director) $403,977 $0 $86,003
Dr Bing Ren (Group Leader) $401,272 $0 $68,994
Xin Lu (Branch Director) $382,032 $0 $51,267
Andrew Shiau (Group Leader) $361,737 $0 $61,491
Patrice Morin (Deputy Scient. Dir.) $313,974 $0 $73,833
John L Notter (Director, Board Chairperson) $28,701 $127,788 $0
John D Gordan Iii (Director) $10,934 $82,788 $0
Jedd Wolchok (Director) $10,934 $82,788 $0
Dr Nancy Ellen Davidson (Director) $10,934 $30,000 $0
Judge Barbara S Jones (Director) $10,934 $30,000 $0
Alexandra Johnson (Director) $10,934 $30,000 $0
Nicolas Killen (Director) $10,934 $30,000 $0
Edward A Mc Dermott Jr (Director, President) $0 $951,807 $93,653

Document Links

Fiscal Year Ending Dec.
2022

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$102,443,688
Expenses
$107,869,697
Net Income
-$5,426,009
Net Assets
$2,030,031
Notable Sources of Revenue Percent of Total Revenue
Contributions $90,702,581
88.5%
Program Services $0
Investment Income $3,836
0.0%
Bond Proceeds $0
Royalties $2,647,436
2.6%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $9,089,835
8.9%
Notable Expenses Percent of Total Expenses
Executive Compensation $3,647,969
3.4%
Professional Fundraising Fees $0
Other Salaries and Wages $15,801,098
14.6%
Assets/Debt
Total Assets $21,583,740
Total Liabilities $19,553,709
Net Assets $2,030,031
Compensation
Key Employees and Officers Compensation Related Other
Dr Don Cleveland (Group Leader) $1,140,218 $0 $71,235
Dr Chi Van Dang (Director, Scientific Director) $1,017,288 $0 $70,763
Dr Richard Kolodner (Group Leader) $877,903 $0 $75,621
Dr Jonathan Skipper (Exec Vice Pres Tech Develop.) $766,905 $0 $71,877
Dr Bing Ren (Group Leader) $724,603 $0 $79,101
Dr Ralph Venhaus (Chief Medical Officer) $536,028 $0 $71,763
Arshad Desai (Group Leader) $529,700 $0 $53,700
Thomas Baenninger (Chief Financial Officer) $486,505 $0 $109,936
George Coukos (Branch Director) $383,674 $0 $86,799
Xin Lu (Branch Director) $366,682 $0 $48,226
Patrice Morin (Deputy Scient. Dir. (Since Aug) $136,887 $0 $16,109
John L Notter (Director, Board Chairperson) $27,259 $123,876 $0
John D Gordan Iii (Director) $10,384 $78,876 $0
Dr Nancy Ellen Davidson (Director) $10,384 $30,000 $0
Olivier R E Dunant (Director, Vice Chair) $10,384 $30,000 $0
Judge Barbara S Jones (Director) $10,384 $30,000 $0
Alexandra Johnson (Director) $10,384 $30,000 $0
Dr Philip A Pizzo (Director (To Aug. 2022)) $6,923 $20,000 $0
Edward A Mcdermott Jr (Director, President) $0 $916,361 $101,470

Document Links

Fiscal Year Ending Dec.
2021

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$89,264,708
Expenses
$90,029,244
Net Income
-$764,536
Net Assets
$3,898,763
Notable Sources of Revenue Percent of Total Revenue
Contributions $60,948,408
68.3%
Program Services $0
Investment Income $277,032
0.3%
Bond Proceeds $0
Royalties $2,480,060
2.8%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $22,498,726
25.2%
Net Inventory Sales $0
Other Revenue $3,060,482
3.4%
Notable Expenses Percent of Total Expenses
Executive Compensation $3,352,127
3.7%
Professional Fundraising Fees $0
Other Salaries and Wages $16,328,237
18.1%
Assets/Debt
Total Assets $25,811,385
Total Liabilities $21,912,622
Net Assets $3,898,763
Other
Provided first-class or charter travel
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Dr Chi Van Dang (Director, Scientific Director) $939,103 $0 $67,411
Dr Jonathan Skipper (Exec Vice Pres Tech Develop.) $717,110 $0 $68,407
Dr Don Cleveland (Group Leader) $675,948 $0 $71,604
Dr Richard Kolodner (Group Leader) $546,080 $0 $75,164
Dr Ralph Venhaus (Chief Medical Officer) $500,432 $0 $68,464
Dr Bing Ren (Group Leader) $470,258 $0 $67,425
Thomas Baenninger (Chief Financial Officer) $453,265 $0 $101,455
Xin Lu (Branch Director) $390,854 $0 $52,365
George Coukos (Branch Director) $382,842 $0 $85,985
Rachel Reinhardt (Vice President Communications) $341,610 $0 $67,401
John L Notter (Director, Board Chairperson) $28,431 $121,684 $0
John D Gordan Iii (Director) $10,831 $76,684 $0
Dr Nancy Ellen Davidson (Director) $10,831 $30,000 $0
Olivier R E Dunant (Director, Vice Chair) $10,831 $30,000 $0
Judge Barbara S Jones (Director) $10,831 $30,000 $0
Alexandra Johnson (Director) $10,831 $30,000 $0
Dr Philip A Pizzo (Director) $10,831 $30,000 $0
Edward A Mcdermott Jr (Director, President) $0 $916,864 $103,318

Document Links

Fiscal Year Ending Dec.
2020

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$77,577,808
Expenses
$72,855,425
Net Income
$4,722,383
Net Assets
$5,002,270
Notable Sources of Revenue Percent of Total Revenue
Contributions $74,459,168
96.0%
Program Services $0
Investment Income $40,567
0.1%
Bond Proceeds $0
Royalties $1,742,642
2.2%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $228,811
0.3%
Net Inventory Sales $0
Other Revenue $1,106,620
1.4%
Notable Expenses Percent of Total Expenses
Executive Compensation $3,662,660
5.0%
Professional Fundraising Fees $0
Other Salaries and Wages $18,284,963
25.1%
Assets/Debt
Total Assets $31,531,617
Total Liabilities $26,529,347
Net Assets $5,002,270
Other
Provided first-class or charter travel
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Dr Chi Van Dang (Director, Scientific Director) $931,911 $0 $65,335
Dr Jonathan Skipper (Exec Vice Pres Tech Develop.) $712,031 $0 $65,444
Dr Don Cleveland (Group Leader) $678,640 $0 $71,066
Dr Richard Kolodner (Group Leader) $546,550 $0 $74,636
Dr Paul Mischel (Group Leader) $504,448 $0 $70,351
Dr Ralph Venhaus (Chief Medical Officer) $496,283 $0 $64,865
Dr Bing Ren (Group Leader) $471,019 $0 $62,020
Thomas Baenninger (Chief Financial Officer) $436,802 $0 $96,758
George Coukos (Branch Director) $352,237 $0 $78,120
Rachel Reinhardt (Vice President Communications) $342,283 $0 $44,679
Dr Robert Strausberg (Deputy Scient. Dir. To Feb2020) $255,126 $0 $18,055
John L Notter (Director, Board Chairperson) $27,398 $121,116 $0
John D Gordan Iii (Director) $10,437 $76,116 $0
Dr Nancy Ellen Davidson (Director) $10,437 $30,000 $0
Olivier R E Dunant (Director, Vice Chair) $10,437 $30,000 $0
Judge Barbara S Jones (Director) $10,437 $30,000 $0
Alexandra Johnson (Director) $10,437 $30,000 $0
Dr Philip A Pizzo (Director) $10,437 $30,000 $0
Edward A Mcdermott Jr (Director, President) $0 $915,836 $96,405

Document Links

Fiscal Year Ending Dec.
2019

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$80,485,740
Expenses
$81,502,785
Net Income
-$1,017,045
Net Assets
$1,775,245
Notable Sources of Revenue Percent of Total Revenue
Contributions $73,436,659
91.2%
Program Services $0
Investment Income $185,972
0.2%
Bond Proceeds $0
Royalties $2,230,765
2.8%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $4,444,341
5.5%
Net Inventory Sales $0
Other Revenue $188,003
0.2%
Notable Expenses Percent of Total Expenses
Executive Compensation $4,368,077
5.4%
Professional Fundraising Fees $0
Other Salaries and Wages $19,766,292
24.3%
Assets/Debt
Total Assets $32,064,163
Total Liabilities $30,288,918
Net Assets $1,775,245
Other
Provided first-class or charter travel
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Dr Chi Van Dang (Director, Scientific Director) $908,064 $0 $63,501
Dr Don Cleveland (Group Leader) $677,952 $0 $67,551
Dr Jonathan Skipper (Exec Vice Pres Tech Develop.) $600,605 $0 $63,171
Dr Webster Cavenee (Dir Strat Alliances Cns Cancer) $596,960 $0 $48,543
Dr Richard Kolodner (Branch Director To Nov 2019) $596,132 $0 $68,567
Dr Robert Strausberg (Deputy Scientific Director) $536,900 $0 $43,376
Dr Paul Mischel (Group Leader) $505,208 $0 $68,028
Dr Ralph Venhaus (Chief Medical Officer) $477,269 $0 $62,689
Dr Bing Ren (Group Leader) $471,779 $0 $53,683
Thomas Baenninger (Chief Financial Officer) $384,307 $0 $85,585
Rachel Reinhardt (Vice President Communications) $328,785 $0 $43,508
George Coukos (Branch Director) $326,043 $0 $72,417
Dr Benoit Van Den Eynd ((Former) Branch Director) $244,502 $0 $167,059
John L Notter (Director, Board Chairperson) $26,135 $120,296 $0
John D Gordan Iii (Director) $9,956 $75,296 $0
Dr Nancy Ellen Davids (Director) $9,956 $30,000 $0
Olivier R E Dunant (Director, Vice Chair) $9,956 $30,000 $0
Judge Barbara S Jones (Director) $9,956 $30,000 $0
Dr Philip A Pizzo (Director) $9,956 $30,000 $0
Alexandra Johnson (Director From Sep 2019) $3,319 $10,000 $0
Edward A Mcdermott Jr (Director, President) $0 $886,968 $104,651

Document Links

Fiscal Year Ending Dec.
2018

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$66,568,790
Expenses
$83,729,729
Net Income
-$17,160,939
Net Assets
$5,068,051
Notable Sources of Revenue Percent of Total Revenue
Contributions $63,413,917
95.3%
Program Services $0
Investment Income $461,144
0.7%
Bond Proceeds $0
Royalties $2,537,437
3.8%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $42,993
0.1%
Net Inventory Sales $0
Other Revenue $113,299
0.2%
Notable Expenses Percent of Total Expenses
Executive Compensation $4,654,094
5.6%
Professional Fundraising Fees $0
Other Salaries and Wages $19,955,612
23.8%
Assets/Debt
Total Assets $35,976,658
Total Liabilities $30,908,607
Net Assets $5,068,051
Other
Provided first-class or charter travel
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Dr Chi Van Dang (Director, Scientific Director) $922,745 $0 $62,345
Dr Don Cleveland (Group Leader) $667,134 $0 $49,588
Dr Richard Kolodner (Branch Director) $595,266 $0 $50,068
Dr Webster Cavenee (Dir Strat Alliances Cns Cancer) $586,569 $0 $49,545
Dr Jonathan Skipper (Exec Dir Tech Development) $538,786 $0 $61,978
Dr Robert Strausberg (Deputy Scientific Director) $535,514 $0 $42,566
Dr Paul Mischel (Group Leader) $469,563 $0 $48,670
Dr Ralph Venhaus (Chief Medical Officer) $457,677 $0 $61,542
Dr Bing Ren (Group Leader) $403,389 $0 $35,603
Richard D J Walker (Cfo And Sec Thru November 2018) $371,673 $0 $62,120
Paul Schwarzenberger (Group Leader) $369,852 $0 $58,991
Thomas Baenninger (Chief Financial Officer) $355,916 $0 $68,209
George Coukos (Branch Director) $321,562 $0 $58,638
Dr Benoit Van Den Eynde ((Former) Branch Director) $251,684 $0 $104,432
John L Notter (Director, Board Chairperson) $26,588 $119,216 $0
Dr Samuel Hellman (Director Thru June 2018) $16,331 $36,778 $0
John D Gordan Iii (Director) $10,129 $74,216 $0
Olivier R E Dunant (Dir, Vice Chair From Dec 2018) $10,129 $30,000 $0
Dr Philip A Pizzo (Director) $10,129 $30,000 $0
Judge Barbara S Jones (Director) $10,129 $30,000 $0
Dr Adolf E Kammerer (Dir, Vice Chair Thru Oct 2018) $8,440 $25,000 $0
Dr Nancy Ellen Davidson (Director From June 2018) $5,064 $15,000 $0
Edward A Mc Dermott Jr (Director, President) $0 $862,797 $164,808

Document Links

Fiscal Year Ending Dec.
2017

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$101,364,787
Expenses
$95,419,637
Net Income
$5,945,150
Net Assets
$22,942,599
Notable Sources of Revenue Percent of Total Revenue
Contributions $96,378,159
95.1%
Program Services $0
Investment Income $516,708
0.5%
Bond Proceeds $0
Royalties $4,465,281
4.4%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $4,639
0.0%
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $3,135,039
3.3%
Professional Fundraising Fees $0
Other Salaries and Wages $27,879,461
29.2%
Assets/Debt
Total Assets $56,060,264
Total Liabilities $33,117,665
Net Assets $22,942,599
Other
Provided first-class or charter travel
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Dr Don Cleveland (Group Leader) $685,827 $0 $47,000
Dr Richard Kolodner (Branch Director) $609,536 $0 $46,979
Dr Webster Cavenee (Dir Strat Alliances Cns Cancer) $600,913 $0 $46,456
Dr Chi Van Dang (Director, Scientific Director) $560,053 $0 $48,567
Dr Jonathan Skipper (Exec. Vice President Tech Dev) $539,895 $0 $62,170
Dr Robert Strausberg (Deputy Scientific Director) $537,849 $0 $61,919
Dr Ralph Venhaus (Chief Medical Officer) $444,540 $0 $58,422
Dr Paul Mischel (Group Leader) $443,839 $0 $48,670
Dr Bing Ren (Group Leader) $423,596 $0 $36,735
Richard D J Walker (Cfo And Secretary To Board) $391,451 $0 $78,300
Dr Benoit Van Den Eynde (Branch Director) $232,570 $0 $93,710
John L Notter (Director, Board Chairperson) $26,305 $118,292 $0
Dr Samuel Hellman (Director) $22,139 $73,292 $0
John D Gordan Iii (Director) $10,021 $73,292 $0
Olivier R E Dunant (Director) $10,021 $30,000 $0
Dr Adolf E Kammerer (Director) $10,021 $30,000 $0
Dr Philip A Pizzo (Director) $10,021 $30,000 $0
Judge Barbara S Jones (Director) $10,021 $30,000 $0
Edward A Mcdermott Jr (Director, President) $0 $861,990 $225,595

Document Links

Fiscal Year Ending Dec.
2016

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$95,793,231
Expenses
$99,302,172
Net Income
-$3,508,941
Net Assets
$15,337,181
Notable Sources of Revenue Percent of Total Revenue
Contributions $89,569,179
93.5%
Program Services $0
Investment Income $468,152
0.5%
Bond Proceeds $0
Royalties $5,755,900
6.0%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $2,715,870
2.7%
Professional Fundraising Fees $0
Other Salaries and Wages $27,724,856
27.9%
Assets/Debt
Total Assets $51,287,527
Total Liabilities $35,950,346
Net Assets $15,337,181
Other
Provided first-class or charter travel
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Dr Don Cleveland (Group Leader) $612,818 $0 $56,742
Dr Richard Kolodner (Branch Director) $576,363 $0 $51,953
Dr Webster Cavenee (Dir Strat Alliances Cns Cancer) $566,044 $0 $56,725
Dr Jonathan Skipper (Exec. Dir. Tech Development) $537,894 $0 $56,038
Dr Robert Strausberg (Exec. Dir. Of Collab. Sciences) $515,293 $0 $55,612
Richard D J Walker (Cfo And Secretary To Board) $434,786 $0 $82,040
Dr Ralph Venhaus (Chief Medical Officer) $429,953 $0 $55,928
Dr Paul Mischel (Group Leader) $424,952 $0 $59,891
Juan Presotto (Branch Administratior) $405,714 $0 $14,692
Dr Benoit Van Den Eynde (Branch Director) $228,782 $0 $90,109
Prof Sir David Lane (Scientific Dir,Retired Jun2016) $212,181 $0 $0
John Notter (Director, Board Chairperson) $26,430 $117,752 $0
Dr Samuel Hellman (Director) $25,499 $72,752 $0
John D Gordan Iii (Director) $10,068 $72,752 $0
Olivier R E Dunant (Director) $10,068 $30,000 $0
Dr Adolf E Kammerer (Director, Board Vice Chair) $10,068 $30,000 $0
Phillip A Pizzo (Director) $10,068 $30,000 $0
Stephen Bollenbach (Director,Deceased October 2016) $7,551 $22,500 $0
Alfred Berger (Director, Retired June 2016) $7,306 $15,000 $0
Judge Barbara S Jones (Director As Of December 2016) $857 $2,555 $0
Edward A Mcdermott Jr (Director, President) $0 $850,246 $236,360

Document Links

Fiscal Year Ending Dec.
2015

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$95,626,867
Expenses
$96,178,689
Net Income
-$551,822
Net Assets
$20,129,827
Notable Sources of Revenue Percent of Total Revenue
Contributions $85,570,660
89.5%
Program Services $0
Investment Income $299,491
0.3%
Bond Proceeds $0
Royalties $9,754,123
10.2%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $2,593
0.0%
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $3,454,025
3.6%
Professional Fundraising Fees $0
Other Salaries and Wages $27,616,647
28.7%
Assets/Debt
Total Assets $51,106,714
Total Liabilities $30,976,887
Net Assets $20,129,827
Other
Provided first-class or charter travel
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Dr Don Cleveland (Group Leader) $594,867 $0 $59,274
Dr Webster Cavenee (Branch Director See Schedule O) $585,216 $0 $64,285
Dr Richard Kolodner (Branch Director See Schedule O) $559,670 $0 $50,899
Dr Jonathan Skipper (Exec. Dir. Tech Development) $529,439 $0 $53,817
Hugh R Macdonald (Group Leader) $502,209 $0 $31,722
Dr Eric W Hoffman (Exec. Dir. Operations) $491,789 $0 $53,275
Richard D J Walker (Cfo And Secretary To Board) $478,390 $0 $89,043
Dr Robert Strausberg (Exec. Dir. Of Collab. Sciences) $432,839 $0 $53,713
Prof Sir David Lane (Director, Scientific Director) $427,720 $0 $0
Dr Ralph Venhaus (Chief Medical Officer) $419,348 $0 $53,702
Dr Paul Mischel (Group Leader) $406,342 $0 $65,362
Aileen Ryan (Director Clinical Trials Manag) $263,938 $0 $53,421
Dr Benoit Van Den Eynde (Branch Director) $230,760 $0 $88,229
John Notter (Director, Board Chairperson) $27,051 $117,700 $0
Dr Samuel Hellman (Director) $16,862 $72,700 $0
John D Gordan Iii (Director) $10,305 $72,700 $0
Alfred Berger (Director) $10,305 $30,000 $0
Olivier R E Dunant (Director) $10,305 $30,000 $0
Dr Adolf E Kammerer (Director, Board Vice Chair) $10,305 $30,000 $0
Stephen Bollenbach (Director) $10,305 $30,000 $0
Phillip A Pizzo (Director) $10,305 $30,000 $0
Edward A Mcdermott Jr (Director, President) $0 $841,449 $237,771

Document Links

Fiscal Year Ending Dec.
2014

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$107,374,415
Expenses
$100,989,519
Net Income
$6,384,896
Net Assets
$22,340,269
Notable Sources of Revenue Percent of Total Revenue
Contributions $96,832,844
90.2%
Program Services $0
Investment Income $326,408
0.3%
Bond Proceeds $0
Royalties $8,456,766
7.9%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $1,758,397
1.6%
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $4,006,288
4.0%
Professional Fundraising Fees $0
Other Salaries and Wages $32,941,529
32.6%
Assets/Debt
Total Assets $45,533,799
Total Liabilities $23,193,530
Net Assets $22,340,269
Other
Provided first-class or charter travel
Compensation
Key Employees and Officers Compensation Related Other
Dr Webster Cavenee (Branch Director) $605,742 $0 $59,290
Dr Don Cleveland (Group Leader) $559,497 $0 $57,319
Dr Richard Kolodner (Head Of Academic Affairs) $540,931 $0 $50,928
Dr Jonathan Skipper (Exec. Dir. Tech Development) $530,128 $0 $51,650
Richard D J Walker (Cfo And Secretary To Board) $506,634 $0 $95,969
Dr Eric W Hoffman (Exec. Dir. Operations) $492,513 $0 $51,259
Prof Sir David Lane (Director, Scientific Director) $464,319 $0 $0
Dr Robert Strausberg (Exec. Dir. Of Collab. Sciences) $414,195 $0 $51,527
Dr Paul Mischel (Group Leader) $379,847 $0 $60,214
Dr Ralph Venhaus (Chief Medical Officer) $378,255 $0 $51,495
Dr Jonathan Cebon (Branch Director) $326,156 $0 $55,446
Dr Andrew Scott (Former Branch Director) $311,312 $0 $37,337
Dr Benoit Van Den Eynde (Branch Director) $275,305 $0 $98,002
John Notter (Director, Board Chairperson) $28,648 $127,020 $0
Dr Samuel Hellman (Director) $22,260 $92,373 $0
John D Gordan Iii (Director) $10,913 $82,020 $0
Alfred Berger (Director) $10,913 $30,000 $0
Olivier R E Dunant (Director) $10,913 $30,000 $0
Dr Adolf E Kammerer (Director, Board Vice Chair) $10,913 $30,000 $0
Stephen Bollenbach (Director) $10,913 $30,000 $0
Phillip A Pizzo (Director As Of June 24, 2014) $5,667 $15,577 $0
Edward A Mcdermott Jr (Director, President) $0 $851,439 $210,077

Document Links

Fiscal Year Ending Dec.
2013

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$106,821,104
Expenses
$108,070,010
Net Income
-$1,248,906
Net Assets
$16,157,890
Notable Sources of Revenue Percent of Total Revenue
Contributions $98,800,217
92.5%
Program Services $0
Investment Income $290,494
0.3%
Bond Proceeds $0
Royalties $7,727,046
7.2%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $3,347
0.0%
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $4,082,514
3.8%
Professional Fundraising Fees $0
Other Salaries and Wages $34,154,287
31.6%
Assets/Debt
Total Assets $44,071,740
Total Liabilities $27,913,850
Net Assets $16,157,890
Other
Provided first-class or charter travel
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Dr Webster Cavenee (Branch Director) $593,636 $0 $58,956
Dr Richard Kolodner (Head Of Academic Affairs) $530,148 $0 $51,337
Dr Jonathan Skipper (Exec. Dir. Tech Development) $529,581 $0 $48,639
Dr Don Cleveland (Group Leader) $500,246 $0 $57,306
Richard D J Walker (Chief Financial Officer) $494,334 $0 $95,123
Dr Eric W Hoffman (Exec. Dir. Operations) $489,778 $0 $48,248
Dr Andrew Simpson (Former Scientific Director) $410,034 $15,000 $0
Dr Robert Strausberg (Exec. Dir. Of Collab. Sciences) $402,114 $0 $48,502
Dr Ralph Venhaus (Chief Medical Officer) $375,229 $0 $48,477
Dr Paul Mischel (Group Leader) $364,859 $0 $58,043
Dr Andrew Scott (Branch Director Through 2/2013) $334,468 $0 $40,178
Dr Jonathan Cebon (Branch Director (Began 2/2013)) $326,156 $0 $55,446
Prof Sir David Lane (Scientific Director) $272,054 $0 $0
Dr Benoit Van Den Eynde (Branch Director) $268,385 $0 $92,998
John Notter (Director, Board Chairperson) $27,952 $126,412 $0
Dr Samuel Hellman (Director) $22,331 $81,412 $0
John D Gordan Iii (Director) $10,648 $81,412 $0
Alfred Berger (Director) $10,648 $30,000 $0
Olivier R E Dunant (Director) $10,648 $30,000 $0
Dr Adolf E Kammerer (Director,Board Vice Chair) $10,648 $30,000 $0
Stephen Bollenbach (Director) $10,648 $30,000 $0
Edward A Mcdermott Jr (Director, President) $0 $851,048 $213,148

Document Links

Fiscal Year Ending Dec.
2012

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$123,246,281
Expenses
$113,956,738
Net Income
$9,289,543
Net Assets
$17,404,880
Notable Sources of Revenue Percent of Total Revenue
Contributions $114,821,712
93.2%
Program Services $0
Investment Income $488,817
0.4%
Bond Proceeds $0
Royalties $7,910,435
6.4%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $25,317
0.0%
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $4,099,330
3.6%
Professional Fundraising Fees $0
Other Salaries and Wages $40,100,064
35.2%
Assets/Debt
Total Assets $46,825,371
Total Liabilities $29,420,491
Net Assets $17,404,880

Document Links

Fiscal Year Ending Dec.
2011

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$124,827,390
Expenses
$121,114,124
Net Income
$3,713,266
Net Assets
$8,113,956
Notable Sources of Revenue Percent of Total Revenue
Contributions $115,669,227
92.7%
Program Services $0
Investment Income $389,321
0.3%
Bond Proceeds $0
Royalties $8,754,258
7.0%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $14,584
0.0%
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $3,750,782
3.1%
Professional Fundraising Fees $0
Other Salaries and Wages $45,547,654
37.6%
Assets/Debt
Total Assets $46,795,771
Total Liabilities $38,681,815
Net Assets $8,113,956

Document Links

Fiscal Year Ending Dec.
2010

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2009

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2008

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2007

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2006

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2005

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2004

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2003

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2002

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2001

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

About This Data

Nonprofit Explorer includes summary data for nonprofit tax returns and full Form 990 documents, in both PDF and digital formats.

The summary data contains information processed by the IRS during the 2012-2019 calendar years; this generally consists of filings for the 2011-2018 fiscal years, but may include older records. This data release includes only a subset of what can be found in the full Form 990s.

In addition to the raw summary data, we link to PDFs and digital copies of full Form 990 documents wherever possible. This consists of separate releases by the IRS of Form 990 documents processed by the agency, which we update regularly.

We also link to copies of audits nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year since 2016. These audits are copied from the Federal Audit Clearinghouse.

Which Organizations Are Here?

Every organization that has been recognized as tax exempt by the IRS has to file Form 990 every year, unless they make less than $200,000 in revenue and have less than $500,000 in assets, in which case they have to file form 990-EZ. Organizations making less than $50,000 don’t have to file either form but do have to let the IRS they’re still in business via a Form 990N "e-Postcard."

Nonprofit Explorer has organizations claiming tax exemption in each of the 27 subsections of the 501(c) section of the tax code, and which have filed a Form 990, Form 990EZ or Form 990PF. Taxable trusts and private foundations that are required to file a form 990PF are also included. Small organizations filing a Form 990N "e-Postcard" are not included in this data.

Types of Nonprofits

There are 27 nonprofit designations based on the numbered subsections of section 501(c) of the tax code. See the list »

Get the Data

For those interested in acquiring the original data from the source, here’s where our data comes from:

  • Raw filing data. Includes EINs and summary financials as structured data.
  • Exempt Organization profiles. Includes organization names, addresses, etc. You can merge this with the raw filing data using EIN numbers.
  • Form 990 documents. Prior to 2017, these documents were obtained and processed by Public.Resource.org and ProPublica. Bulk PDF downloads since 2017 are available from the IRS.
  • Form 990 documents as XML files. Includes complete filing data (financial details, names of officers, tax schedules, etc.) in machine-readable format. Only available for electronically filed documents. Electronic data released prior to October 2021 is also available through Amazon Web Services.
  • Audits. PDFs of single or program-specific audits for nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year. Available for fiscal year 2015 and later.

API

The data powering this website is available programmatically, via an API. Read the API documentation »